Results 111 to 120 of about 28,980 (179)
Safety of the Selective JAK1 Inhibitor Oclacitinib in Dogs
Journal of Veterinary Pharmacology and Therapeutics, EarlyView.ABSTRACT Apoquel(oclacitinib maleate) as a film‐coated tablet, a selective Janus kinase (JAK)1 inhibitor, was approved by the United States Food and Drug Administration (FDA) in 2013 for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
Steven M. Nederveld +2 more
wiley +1 more source
THE TREATMENT OF CHRONIC PURULENT OTITIS MEDIA BY EXCISION OF THE CARIOUS OSSICLES AND REMOVAL OF OBSTRUCTIONS IN THE TYMPANIC ATTIC [PDF]
, 1891 Christopher J. Colles
openalex +1 more source
THE ASSOCIATION OF SUPPURATIVE DISEASE OF THE NASAL ACCESSORY SINUSES AND ACUTE OTITIS MEDIA IN ADULTS [PDF]
, 1911 CORNELIUS G. COAKLEV
openalex +1 more source
THE SYMPTOMS AND TREATMENT OF THE INTRACRANIAL COMPLICATIONS OF OTITIS MEDIA; WITH CASES.*1 [PDF]
, 1904 Gregory Heaton
openalex +1 more source
Maternal &Child Nutrition, EarlyView.ABSTRACT Malnutrition is a major disease burden in developing countries, particularly in recurrently drought‐affected areas. Despite the Ethiopian government's initiatives to set up stabilization centers in different hospitals to tackle severe acute malnutrition, there is limited data on the time to recover from severe acute malnutrition and its ...
Temesgen Gebeyehu Wondmeneh +1 more
wiley +1 more source
OTITIS MEDIA AS A COMPLICATION OF WHOOPING-COUGH. [PDF]
, 1909 A. Banks Raffle
openalex +1 more source